BRIC諸国医薬品市場の概要、競合分析、2018-2027年予測BRIC Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 BRIC諸国(ブラジル、ロシア、インド、中国)医薬品市場の概要、競合分析、2018年~2027年予測 概要 BRIC諸国(ブラジル、ロシア、インド、中国)の医薬品市場概要、競合分析、および2027年までの予測につ... もっと見る
サマリーBRIC諸国(ブラジル、ロシア、インド、中国)医薬品市場の概要、競合分析、2018年~2027年予測概要 BRIC諸国(ブラジル、ロシア、インド、中国)の医薬品市場概要、競合分析、および2027年までの予測についてまとめました。また、主要な財務指標や市場内の競争圧力の分析を含む主要企業の説明も掲載しています。 主要ハイライト - ブラジル、ロシア連邦、インド、中国(BRICs)は医薬品業界の中でも新興の急成長国であり、2022年の市場総額は2897億ドルであった。2018〜22年のCAGRは12.2%で、中国が最も急成長している国である。 - 医薬品業界では、BRICs諸国の中で中国がトップで、2022年の市場収益は2,132億ドルであった。次いでロシアが319億ドル、インドが242億ドル、ブラジルが204億ドルである。 - 2027年には中国が3,552億ドルでBRICs諸国の医薬品業界をリードし、次いでロシア、インド、ブラジルがそれぞれ400億ドル、326億ドル、200億ドルと予想される。 範囲 - BRICs医薬品市場の規模、成長、主要プレーヤーを特定することで、初級レベルの調査にかかる時間を短縮 - ファイブフォース分析により、BRICs医薬品市場の競争激化度、魅力度を把握 - 主要企業のプロフィールから、BRICs医薬品市場の主要企業の事業と財務実績の詳細を明らかにする - BRICs医薬品市場の将来成長見通しを5年予測で把握することで、プレゼンテーションやピッチに重みを加えることができる - ブラジル、ロシア、インド、中国のデータを比較し、それぞれの国について個別の章を設けています。 購入の理由 - 2022年のBRICs医薬品市場規模は? - 2027年のBRICs医薬品市場規模は? - BRICs医薬品市場の競争力に影響を与える要因は何か? - 過去5年間の市場の推移は? - BRICs医薬品市場における上位競合企業は? 目次Table of Contents1 Introduction 1.1. What is this report about? 1.2. Who is the target reader? 1.3. How to use this report 1.4. Definitions 2 BRIC Pharmaceuticals 2.1. Industry Outlook 3 Pharmaceuticals in Brazil 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in China 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Macroeconomic Indicators 6.1. Country data 7 Pharmaceuticals in India 7.1. Market Overview 7.2. Market Data 7.3. Market Segmentation 7.4. Market outlook 7.5. Five forces analysis 8 Macroeconomic Indicators 8.1. Country data 9 Pharmaceuticals in Russia 9.1. Market Overview 9.2. Market Data 9.3. Market Segmentation 9.4. Market outlook 9.5. Five forces analysis 10 Macroeconomic Indicators 10.1. Country data 11 Company Profiles 11.1. Ache Laboratorios Farmaceuticos SA 11.2. EMS Sigma Pharma 11.3. Yangtze River Pharmaceutical Group 11.4. Shanghai Pharmaceuticals Holding Co Ltd 11.5. Yunnan Baiyao Group Co Ltd 11.6. Guangzhou Pharmaceutical Holdings Ltd 11.7. Sun Pharmaceutical Industries Ltd 11.8. Lupin Ltd 11.9. Dr. Reddy's Laboratories Limited 11.10. Aurobindo Pharma Ltd 11.11. Novartis AG 11.12. Sanofi SA 11.13. Bayer AG 11.14. Les Laboratoires Servier 12 Appendix 12.1. Methodology 12.2. About MarketLine 図表リストList of TablesTable 1: BRIC pharmaceuticals industry, revenue($bn), 2018-27 Table 2: BRIC pharmaceuticals industry, revenue($bn), 2018-22 Table 3: BRIC pharmaceuticals industry, revenue($bn), 2022-27 Table 4: Brazil pharmaceuticals market value: $ billion, 2017-22 Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2022 Table 6: Brazil pharmaceuticals market value forecast: $ billion, 2022–27 Table 7: Brazil size of population (million), 2018–22 Table 8: Brazil gdp (constant 2005 prices, $ billion), 2018–22 Table 9: Brazil gdp (current prices, $ billion), 2018–22 Table 10: Brazil inflation, 2018–22 Table 11: Brazil consumer price index (absolute), 2018–22 Table 12: Brazil exchange rate, 2018–22 Table 13: China pharmaceuticals market value: $ billion, 2017-22 Table 14: China pharmaceuticals market geography segmentation: $ billion, 2022 Table 15: China pharmaceuticals market value forecast: $ billion, 2022–27 Table 16: China size of population (million), 2018–22 Table 17: China gdp (constant 2005 prices, $ billion), 2018–22 Table 18: China gdp (current prices, $ billion), 2018–22 Table 19: China inflation, 2018–22 Table 20: China consumer price index (absolute), 2018–22 Table 21: China exchange rate, 2018–22 Table 22: India pharmaceuticals market value: $ billion, 2017-22 Table 23: India pharmaceuticals market geography segmentation: $ billion, 2022 Table 24: India pharmaceuticals market value forecast: $ billion, 2022–27 Table 25: India size of population (million), 2018–22 Table 26: India gdp (constant 2005 prices, $ billion), 2018–22 Table 27: India gdp (current prices, $ billion), 2018–22 Table 28: India inflation, 2018–22 Table 29: India consumer price index (absolute), 2018–22 Table 30: India exchange rate, 2018–22 Table 31: Russia pharmaceuticals market value: $ billion, 2017-22 Table 32: Russia pharmaceuticals market geography segmentation: $ billion, 2022 Table 33: Russia pharmaceuticals market value forecast: $ billion, 2022–27 Table 34: Russia size of population (million), 2018–22 Table 35: Russia gdp (constant 2005 prices, $ billion), 2018–22 Table 36: Russia gdp (current prices, $ billion), 2018–22 Table 37: Russia inflation, 2018–22 Table 38: Russia consumer price index (absolute), 2018–22 Table 39: Russia exchange rate, 2018–22 Table 40: Ache Laboratorios Farmaceuticos SA: key facts Table 41: Ache Laboratorios Farmaceuticos SA: Key Employees Table 42: EMS Sigma Pharma: key facts Table 43: EMS Sigma Pharma: Key Employees Table 44: Yangtze River Pharmaceutical Group: key facts Table 45: Yangtze River Pharmaceutical Group: Key Employees Table 46: Shanghai Pharmaceuticals Holding Co Ltd: key facts Table 47: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios Table 48: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees Table 49: Yunnan Baiyao Group Co Ltd: key facts Table 50: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios Table 51: Guangzhou Pharmaceutical Holdings Ltd: key facts Table 52: Guangzhou Pharmaceutical Holdings Ltd: Key Employees Table 53: Sun Pharmaceutical Industries Ltd: key facts Table 54: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios Table 55: Sun Pharmaceutical Industries Ltd: Key Employees Table 56: Sun Pharmaceutical Industries Ltd: Key Employees Continued Table 57: Lupin Ltd: key facts Table 58: Lupin Ltd: Annual Financial Ratios Table 59: Lupin Ltd: Key Employees Table 60: Dr. Reddy's Laboratories Limited: key facts Table 61: Dr. Reddy's Laboratories Limited: Annual Financial Ratios Table 62: Dr. Reddy's Laboratories Limited: Key Employees Table 63: Aurobindo Pharma Ltd: key facts Table 64: Aurobindo Pharma Ltd: Annual Financial Ratios Table 65: Aurobindo Pharma Ltd: Key Employees Table 66: Novartis AG: key facts Table 67: Novartis AG: Annual Financial Ratios Table 68: Novartis AG: Key Employees Table 69: Novartis AG: Key Employees Continued Table 70: Sanofi SA: key facts Table 71: Sanofi SA: Annual Financial Ratios Table 72: Sanofi SA: Key Employees Table 73: Sanofi SA: Key Employees Continued Table 74: Bayer AG: key facts Table 75: Bayer AG: Annual Financial Ratios Table 76: Bayer AG: Key Employees Table 77: Bayer AG: Key Employees Continued Table 78: Les Laboratoires Servier: key facts Table 79: Les Laboratoires Servier: Key Employees
SummaryBRIC Countries (Brazil, Russia, India, China) Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 Table of ContentsTable of Contents1 Introduction 1.1. What is this report about? 1.2. Who is the target reader? 1.3. How to use this report 1.4. Definitions 2 BRIC Pharmaceuticals 2.1. Industry Outlook 3 Pharmaceuticals in Brazil 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in China 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Macroeconomic Indicators 6.1. Country data 7 Pharmaceuticals in India 7.1. Market Overview 7.2. Market Data 7.3. Market Segmentation 7.4. Market outlook 7.5. Five forces analysis 8 Macroeconomic Indicators 8.1. Country data 9 Pharmaceuticals in Russia 9.1. Market Overview 9.2. Market Data 9.3. Market Segmentation 9.4. Market outlook 9.5. Five forces analysis 10 Macroeconomic Indicators 10.1. Country data 11 Company Profiles 11.1. Ache Laboratorios Farmaceuticos SA 11.2. EMS Sigma Pharma 11.3. Yangtze River Pharmaceutical Group 11.4. Shanghai Pharmaceuticals Holding Co Ltd 11.5. Yunnan Baiyao Group Co Ltd 11.6. Guangzhou Pharmaceutical Holdings Ltd 11.7. Sun Pharmaceutical Industries Ltd 11.8. Lupin Ltd 11.9. Dr. Reddy's Laboratories Limited 11.10. Aurobindo Pharma Ltd 11.11. Novartis AG 11.12. Sanofi SA 11.13. Bayer AG 11.14. Les Laboratoires Servier 12 Appendix 12.1. Methodology 12.2. About MarketLine List of Tables/GraphsList of TablesTable 1: BRIC pharmaceuticals industry, revenue($bn), 2018-27 Table 2: BRIC pharmaceuticals industry, revenue($bn), 2018-22 Table 3: BRIC pharmaceuticals industry, revenue($bn), 2022-27 Table 4: Brazil pharmaceuticals market value: $ billion, 2017-22 Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2022 Table 6: Brazil pharmaceuticals market value forecast: $ billion, 2022–27 Table 7: Brazil size of population (million), 2018–22 Table 8: Brazil gdp (constant 2005 prices, $ billion), 2018–22 Table 9: Brazil gdp (current prices, $ billion), 2018–22 Table 10: Brazil inflation, 2018–22 Table 11: Brazil consumer price index (absolute), 2018–22 Table 12: Brazil exchange rate, 2018–22 Table 13: China pharmaceuticals market value: $ billion, 2017-22 Table 14: China pharmaceuticals market geography segmentation: $ billion, 2022 Table 15: China pharmaceuticals market value forecast: $ billion, 2022–27 Table 16: China size of population (million), 2018–22 Table 17: China gdp (constant 2005 prices, $ billion), 2018–22 Table 18: China gdp (current prices, $ billion), 2018–22 Table 19: China inflation, 2018–22 Table 20: China consumer price index (absolute), 2018–22 Table 21: China exchange rate, 2018–22 Table 22: India pharmaceuticals market value: $ billion, 2017-22 Table 23: India pharmaceuticals market geography segmentation: $ billion, 2022 Table 24: India pharmaceuticals market value forecast: $ billion, 2022–27 Table 25: India size of population (million), 2018–22 Table 26: India gdp (constant 2005 prices, $ billion), 2018–22 Table 27: India gdp (current prices, $ billion), 2018–22 Table 28: India inflation, 2018–22 Table 29: India consumer price index (absolute), 2018–22 Table 30: India exchange rate, 2018–22 Table 31: Russia pharmaceuticals market value: $ billion, 2017-22 Table 32: Russia pharmaceuticals market geography segmentation: $ billion, 2022 Table 33: Russia pharmaceuticals market value forecast: $ billion, 2022–27 Table 34: Russia size of population (million), 2018–22 Table 35: Russia gdp (constant 2005 prices, $ billion), 2018–22 Table 36: Russia gdp (current prices, $ billion), 2018–22 Table 37: Russia inflation, 2018–22 Table 38: Russia consumer price index (absolute), 2018–22 Table 39: Russia exchange rate, 2018–22 Table 40: Ache Laboratorios Farmaceuticos SA: key facts Table 41: Ache Laboratorios Farmaceuticos SA: Key Employees Table 42: EMS Sigma Pharma: key facts Table 43: EMS Sigma Pharma: Key Employees Table 44: Yangtze River Pharmaceutical Group: key facts Table 45: Yangtze River Pharmaceutical Group: Key Employees Table 46: Shanghai Pharmaceuticals Holding Co Ltd: key facts Table 47: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios Table 48: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees Table 49: Yunnan Baiyao Group Co Ltd: key facts Table 50: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios Table 51: Guangzhou Pharmaceutical Holdings Ltd: key facts Table 52: Guangzhou Pharmaceutical Holdings Ltd: Key Employees Table 53: Sun Pharmaceutical Industries Ltd: key facts Table 54: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios Table 55: Sun Pharmaceutical Industries Ltd: Key Employees Table 56: Sun Pharmaceutical Industries Ltd: Key Employees Continued Table 57: Lupin Ltd: key facts Table 58: Lupin Ltd: Annual Financial Ratios Table 59: Lupin Ltd: Key Employees Table 60: Dr. Reddy's Laboratories Limited: key facts Table 61: Dr. Reddy's Laboratories Limited: Annual Financial Ratios Table 62: Dr. Reddy's Laboratories Limited: Key Employees Table 63: Aurobindo Pharma Ltd: key facts Table 64: Aurobindo Pharma Ltd: Annual Financial Ratios Table 65: Aurobindo Pharma Ltd: Key Employees Table 66: Novartis AG: key facts Table 67: Novartis AG: Annual Financial Ratios Table 68: Novartis AG: Key Employees Table 69: Novartis AG: Key Employees Continued Table 70: Sanofi SA: key facts Table 71: Sanofi SA: Annual Financial Ratios Table 72: Sanofi SA: Key Employees Table 73: Sanofi SA: Key Employees Continued Table 74: Bayer AG: key facts Table 75: Bayer AG: Annual Financial Ratios Table 76: Bayer AG: Key Employees Table 77: Bayer AG: Key Employees Continued Table 78: Les Laboratoires Servier: key facts Table 79: Les Laboratoires Servier: Key Employees
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
MarketLine 社の最新刊レポート本レポートと同じKEY WORD(competitive analysis)の最新刊レポートよくあるご質問MarketLine社はどのような調査会社ですか?マーケットライン(MarketLine)は、世界の産業および企業を国別や業種別に詳細に調査し、調査レポートを積極的に出版しています。また世界の企業を幅広く対象に様々な角度から調査した企業レポートも出版... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/09 10:27 143.78 円 159.73 円 191.51 円 |